I think that ideally it would be more advantageous if that partner Was in the biotech field, not sure what non biotech entity could take this up, any ideas?
Biotech partner would have the advantage of established network, distribution and marketing in place in this field, looking at it from a layman’s point of view but it does seem to make sense until I am enlightened otherwise.
- Forums
- ASX - By Stock
- AVR
- Schwarzenegger has valve replacement by catheter.
Schwarzenegger has valve replacement by catheter., page-46
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.65 |
Change
-0.060(0.38%) |
Mkt cap ! $300.8M |
Open | High | Low | Value | Volume |
$15.72 | $15.85 | $15.51 | $1.660M | 117.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 312 | $15.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.65 | 626 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 312 | 15.510 |
1 | 650 | 15.500 |
1 | 646 | 15.490 |
1 | 6 | 15.450 |
1 | 50 | 15.400 |
Price($) | Vol. | No. |
---|---|---|
15.880 | 250 | 1 |
16.000 | 134 | 1 |
16.200 | 200 | 1 |
16.250 | 1000 | 1 |
16.500 | 1034 | 2 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |